Kentucky 2024 Regular Session

Kentucky House Bill HB63

Introduced
1/2/24  

Caption

AN ACT relating to coverage for annual pap smears.

Impact

If passed, HB 63 will modify existing state law regarding healthcare coverage, reinforcing the importance of preventive health measures. Insurers will be required to comply with this mandate by providing coverage for annual pap smears as part of their health benefit plans. This change is expected to lead to increased rates of cervical cancer screening among women, thereby potentially facilitating early detection and treatment, ultimately improving health outcomes in the state. The bill is set to take effect on January 1, 2025, indicating lawmakers' intention to give insurers time to adjust their policies accordingly.

Summary

House Bill 63 proposes that all health insurance policies, including plans for public employees, must provide coverage for annual pap smears without a referral from a primary care provider. This bill emphasizes preventive healthcare for women by ensuring that routine screenings for cervical cancer are accessible and financially manageable. The legislation aims to remove unnecessary barriers and cost-sharing burdens typically associated with such preventive services, which can discourage women from obtaining necessary health screenings.

Sentiment

The sentiment surrounding HB 63 appears predominantly positive, particularly among advocates of women's health. Supporters argue that removing financial barriers will lead to improved health statistics and access to necessary screenings that can save lives. However, there may also be concerns from insurance providers about the financial implications of mandatory coverage for preventive services without cost-sharing, which could impact their overall pricing structures. As such, while the bill is aimed at enhancing healthcare access, it also reflects a tension between health policy objectives and the economic realities of insurance administrators.

Contention

While the bill has garnered positive attention for its focus on women’s health, it is not without points of contention. Insurers might raise concerns regarding the financial ramifications of mandating coverage without cost-sharing for preventive services. There is potential pushback regarding how this mandate could affect overall premium costs, complicating discussions about healthcare affordability. Additionally, discussions may arise on whether certain provisions of the bill are overly prescriptive, possibly limiting insurers' ability to create tailored healthcare plans that could serve different demographics effectively.

Companion Bills

No companion bills found.

Similar Bills

KY HB68

AN ACT relating to coverage for injectable epinephrine devices.

KY HB412

AN ACT relating to coverage for the treatment of postpartum mood disorders.

KY HB98

AN ACT relating to coverage for hepatitis C virus infection testing and treatment in pregnant women.

KY HB183

AN ACT relating to coverage for injectable epinephrine devices.

KY HB709

AN ACT relating to mental health coverage in connection with pregnancy.

KY HB55

AN ACT relating to coverage of mental health wellness examinations.

KY HB443

AN ACT relating to coverage for parental and guardian depression screenings.

KY HB768

AN ACT relating to coverage for cranial conditions.